{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T16:25:45Z","timestamp":1790267145643,"version":"4.1.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,8,20]],"date-time":"2018-08-20T00:00:00Z","timestamp":1534723200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Endocrine"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1007\/s12020-018-1720-3","type":"journal-article","created":{"date-parts":[[2018,8,20]],"date-time":"2018-08-20T07:39:41Z","timestamp":1534750781000},"page":"26-33","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Routine thyroglobulin, neck ultrasound and physical examination in the routine follow up of patients with differentiated thyroid cancer\u2014Where is the evidence?"],"prefix":"10.1007","volume":"62","author":[{"given":"Jessica L.","family":"Gray","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gautam","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lesley","family":"Uttley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saba P.","family":"Balasubramanian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,8,20]]},"reference":[{"issue":"1","key":"1720_CR1","first-page":"9","volume":"3","author":"H Katoh","year":"2015","unstructured":"H. Katoh, K. Yamashita, T. Enomoto, M. Watanabe, Classification and general considerations of thyroid cancer. Ann. Clin. Pathol. 3(1), 9 (2015)","journal-title":"Ann. Clin. Pathol."},{"issue":"11","key":"1720_CR2","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1038\/nrendo.2016.110","volume":"12","author":"CM Kitahara","year":"2016","unstructured":"C.M. Kitahara, J.A. Sosa, The changing incidence of thyroid cancer. Nat. Rev. Endocrinol. 12(11), 646\u2013653 (2016). https:\/\/doi.org\/10.1038\/nrendo.2016.110","journal-title":"Nat. Rev. Endocrinol."},{"issue":"9","key":"1720_CR3","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1038\/bjc.2016.304","volume":"115","author":"CR Smittenaar","year":"2016","unstructured":"C.R. Smittenaar, K.A. Petersen, K. Stewart, N. Moitt, Cancer incidence and mortality projections in the UK until 2035. Br. J. Cancer 115(9), 1147\u20131155 (2016). https:\/\/doi.org\/10.1038\/bjc.2016.304","journal-title":"Br. J. Cancer"},{"issue":"1","key":"1720_CR4","doi-asserted-by":"publisher","first-page":"53","DOI":"10.7497\/j.issn.2095-3941.2015.0005","volume":"12","author":"EM Aboelnaga","year":"2015","unstructured":"E.M. Aboelnaga, R.A. Ahmed, Difference between papillary and follicular thyroid carcinoma outcomes: an experience from Egyptian institution. Cancer Biol. Med. 12(1), 53\u201359 (2015). https:\/\/doi.org\/10.7497\/j.issn.2095-3941.2015.0005","journal-title":"Cancer Biol. Med."},{"issue":"2","key":"1720_CR5","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1677\/erc.1.00892","volume":"12","author":"TP Links","year":"2005","unstructured":"T.P. Links, K.M. van Tol, P.L. Jager, J.T. Plukker, D.A. Piers, H.M. Boezen, R.P. Dullaart, E.G. de Vries, W.J. Sluiter, Life expectancy in differentiated thyroid cancer: a novel approach to survival analysis. Endocr. Relat. Cancer 12(2), 273\u2013280 (2005). https:\/\/doi.org\/10.1677\/erc.1.00892","journal-title":"Endocr. Relat. Cancer"},{"issue":"Suppl. 1","key":"1720_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/cen.12515","volume":"81","author":"P Perros","year":"2014","unstructured":"P. Perros, K. Boelaert, S. Colley, C. Evans, R.M. Evans, G. Gerrard Ba, J. Gilbert, B. Harrison, S.J. Johnson, T.E. Giles, L. Moss, V. Lewington, K. Newbold, J. Taylor, R.V. Thakker, J. Watkinson, G.R. Williams, A. British Thyroid, Guidelines for the management of thyroid cancer. Clin. Endocrinol. (Oxf.). 81(Suppl. 1), 1\u2013122 (2014). https:\/\/doi.org\/10.1111\/cen.12515","journal-title":"Clin. Endocrinol. (Oxf.)."},{"issue":"6","key":"1720_CR7","doi-asserted-by":"crossref","first-page":"9","DOI":"10.5603\/EP.a2015.0060","volume":"66","author":"K Gadawska-Juszczyk","year":"2015","unstructured":"K. Gadawska-Juszczyk, A. Kowalska, Comparison of the usefulness of post-ablative and post-operative thyroglobulin concentration measuring in prognostic assessment of patients with differentiated thyroid cancer. Endokrynol. Pol. 66(6), 9 (2015)","journal-title":"Endokrynol. Pol."},{"issue":"5","key":"1720_CR8","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1089\/thy.1999.9.421","volume":"9","author":"EL Mazzaferri","year":"1999","unstructured":"E.L. Mazzaferri, An overview of the management of papillary and follicular thyroid carcinoma. Thyroid 9(5), 421\u2013427 (1999). https:\/\/doi.org\/10.1089\/thy.1999.9.421","journal-title":"Thyroid"},{"issue":"1","key":"1720_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1089\/thy.2015.0020","volume":"26","author":"BR Haugen","year":"2016","unstructured":"B.R. Haugen, E.K. Alexander, K.C. Bible, G.M. Doherty, S.J. Mandel, Y.E. Nikiforov, F. Pacini, G.W. Randolph, A.M. Sawka, M. Schlumberger, K.G. Schuff, S.I. Sherman, J.A. Sosa, D.L. Steward, R.M. Tuttle, L. Wartofsky, 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer. Thyroid 26(1), 1\u2013133 (2016). https:\/\/doi.org\/10.1089\/thy.2015.0020","journal-title":"Thyroid"},{"issue":"Suppl. 5","key":"1720_CR10","doi-asserted-by":"publisher","first-page":"v214","DOI":"10.1093\/annonc\/mdq190","volume":"21","author":"F Pacini","year":"2010","unstructured":"F. Pacini, M.G. Castagna, L. Brilli, G. Pentheroudakis, E.G.W. Group, Thyroid cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann. Oncol. 21(Suppl. 5), v214\u2013v219 (2010). https:\/\/doi.org\/10.1093\/annonc\/mdq190","journal-title":"Ann. Oncol."},{"issue":"8","key":"1720_CR11","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1089\/thy.2014.0052","volume":"24","author":"ZF Ma","year":"2014","unstructured":"Z.F. Ma, S.A. Skeaff, Thyroglobulin as a biomarker of iodine deficiency: a review. Thyroid 24(8), 1195\u20131209 (2014). https:\/\/doi.org\/10.1089\/thy.2014.0052","journal-title":"Thyroid"},{"issue":"6","key":"1720_CR12","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1016\/S0753-3322(00)80058-X","volume":"54","author":"ME Girelli","year":"2000","unstructured":"M.E. Girelli, D. De Vido, Serum thyroglobulin measurements in differentiated thyroid cancer. Biomed. Pharmacother. 54(6), 330\u2013333 (2000). https:\/\/doi.org\/10.1016\/S0753-3322(00)80058-X","journal-title":"Biomed. Pharmacother."},{"issue":"10","key":"1720_CR13","doi-asserted-by":"publisher","first-page":"3623","DOI":"10.1210\/jcem.85.10.6876","volume":"85","author":"RP Biscolla","year":"2000","unstructured":"R.P. Biscolla, J.M. Cerutti, R.M. Maciel, Detection of recurrent thyroid cancer by sensitive nested reverse transcription-polymerase chain reaction of thyroglobulin and sodium\/iodide symporter messenger ribonucleic acid transcripts in peripheral blood. J. Clin. Endocrinol. Metab. 85(10), 3623\u20133627 (2000). https:\/\/doi.org\/10.1210\/jcem.85.10.6876","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"12","key":"1720_CR14","doi-asserted-by":"publisher","first-page":"4589","DOI":"10.1210\/jc.2014-1203","volume":"99","author":"C Spencer","year":"2014","unstructured":"C. Spencer, I. Petrovic, S. Fatemi, J. LoPresti, Serum thyroglobulin (Tg) monitoring of patients with differentiated thyroid cancer using sensitive (second-generation) immunometric assays can be disrupted by false-negative and false-positive serum thyroglobulin autoantibody misclassifications. J. Clin. Endocrinol. Metab. 99(12), 4589\u20134599 (2014). https:\/\/doi.org\/10.1210\/jc.2014-1203","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"1","key":"1720_CR15","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1002\/jso.10089","volume":"80","author":"JD Lin","year":"2002","unstructured":"J.D. Lin, M.J. Huang, B.R. Hsu, T.C. Chao, C. Hsueh, F.H. Liu, M.J. Liou, H.F. Weng, Significance of postoperative serum thyroglobulin levels in patients with papillary and follicular thyroid carcinomas. J. Surg. Oncol. 80(1), 45\u201351 (2002). https:\/\/doi.org\/10.1002\/jso.10089","journal-title":"J. Surg. Oncol."},{"issue":"5","key":"1720_CR16","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1046\/j.1365-2265.2003.01744.x","volume":"58","author":"G Pellegriti","year":"2003","unstructured":"G. Pellegriti, C. Scollo, C. Regalbuto, M. Attard, P. Marozzi, F. Vermiglio, M.A. Violi, M. Cianci, R. Vigneri, V. Pezzino, S. Squatrito, The diagnostic use of the rhTSH\/thyroglobulin test in differentiated thyroid cancer patients with persistent disease and low thyroglobulin levels. Clin. Endocrinol. (Oxf.). 58(5), 556\u2013561 (2003)","journal-title":"Clin. Endocrinol. (Oxf.)."},{"issue":"12","key":"1720_CR17","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1089\/thy.2006.16.1273","volume":"16","author":"SH Huang","year":"2006","unstructured":"S.H. Huang, P.W. Wang, Y.E. Huang, F.F. Chou, R.T. Liu, S.C. Tung, J.F. Chen, M.C. Kuo, J.R. Hsieh, H.H. Hsieh, Sequential follow-up of serum thyroglobulin and whole body scan in thyroid cancer patients without initial metastasis. Thyroid 16(12), 1273\u20131278 (2006). https:\/\/doi.org\/10.1089\/thy.2006.16.1273","journal-title":"Thyroid"},{"issue":"3","key":"1720_CR18","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1634\/theoncologist.2009-0324","volume":"15","author":"JI Lew","year":"2010","unstructured":"J.I. Lew, C.C. Solorzano, Use of ultrasound in the management of thyroid cancer. Oncologist 15(3), 253\u2013258 (2010). https:\/\/doi.org\/10.1634\/theoncologist.2009-0324","journal-title":"Oncologist"},{"issue":"1","key":"1720_CR19","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1002\/cncr.11031","volume":"97","author":"A Frasoldati","year":"2003","unstructured":"A. Frasoldati, M. Pesenti, M. Gallo, A. Caroggio, D. Salvo, R. Valcavi, Diagnosis of neck recurrences in patients with differentiated thyroid carcinoma. Cancer 97(1), 90\u201396 (2003). https:\/\/doi.org\/10.1002\/cncr.11031","journal-title":"Cancer"},{"issue":"5","key":"1720_CR20","doi-asserted-by":"publisher","first-page":"1390","DOI":"10.1016\/j.surg.2015.11.018","volume":"159","author":"LY Wang","year":"2016","unstructured":"L.Y. Wang, B.R. Roman, F.L. Palmer, R.M. Tuttle, A.R. Shaha, J.P. Shah, S.G. Patel, I. Ganly, Effectiveness of routine ultrasonographic surveillance of patients with low-risk papillary carcinoma of the thyroid. Surgery 159(5), 1390\u20131395 (2016). https:\/\/doi.org\/10.1016\/j.surg.2015.11.018","journal-title":"Surgery"},{"issue":"12","key":"1720_CR21","doi-asserted-by":"publisher","first-page":"1372","DOI":"10.4158\/EP15851.OR","volume":"21","author":"SP Yang","year":"2015","unstructured":"S.P. Yang, A.M. Bach, R.M. Tuttle, S.A. Fish, Serial neck ultrasound is more likely to identify false-positive abnormalities than clinically significant disease in low-risk papillary thyroid cancer patients. Endocr. Pract. 21(12), 1372\u20131379 (2015). https:\/\/doi.org\/10.4158\/EP15851.OR","journal-title":"Endocr. Pract."},{"issue":"4","key":"1720_CR22","doi-asserted-by":"publisher","first-page":"264","DOI":"10.7326\/0003-4819-151-4-200908180-00135","volume":"151","author":"D Moher","year":"2009","unstructured":"D. Moher, A. Liberati, J. Tetzlaff, D.G. Altman, P. Group, Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann. Intern. Med. 151(4), 264\u2013269 (2009). W264","journal-title":"Ann. Intern. Med."},{"issue":"3","key":"1720_CR23","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1177\/000313480306900312","volume":"69","author":"MF Conrad","year":"2003","unstructured":"M.F. Conrad, K.K. Pandurangi, M. Parikshak, E.D. Castillo, G.B. Talpos, Postoperative surveillance of differentiated thyroid carcinoma: a selective approach. Am. Surg. 69(3), 244\u2013250 (2003). discussion 250-241","journal-title":"Am. Surg."},{"issue":"1","key":"1720_CR24","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1530\/EJE-07-0399","volume":"158","author":"HT Phan","year":"2008","unstructured":"H.T. Phan, P.L. Jager, J.E. van der Wal, W.J. Sluiter, J.T. Plukker, R.A. Dierckx, B.H. Wolffenbuttel, T.P. Links, The follow-up of patients with differentiated thyroid cancer and undetectable thyroglobulin (Tg) and Tg antibodies during ablation. Eur. J. Endocrinol.\/Eur. Fed. Endocr. Soc. 158(1), 77\u201383 (2008). https:\/\/doi.org\/10.1530\/EJE-07-0399","journal-title":"Eur. J. Endocrinol.\/Eur. Fed. Endocr. Soc."},{"issue":"5","key":"1720_CR25","doi-asserted-by":"publisher","first-page":"2007","DOI":"10.1007\/s00520-015-2981-5","volume":"24","author":"JL Bender","year":"2016","unstructured":"J.L. Bender, D. Wiljer, A.M. Sawka, R. Tsang, N. Alkazaz, J.D. Brierley, Thyroid cancer survivors\u2019 perceptions of survivorship care follow-up options: a cross-sectional, mixed-methods survey. Support Care Cancer 24(5), 2007\u20132015 (2016). https:\/\/doi.org\/10.1007\/s00520-015-2981-5","journal-title":"Support Care Cancer"},{"issue":"3","key":"1720_CR26","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1210\/jc.2002-021365","volume":"88","author":"E Baudin","year":"2003","unstructured":"E. Baudin, C. Do Cao, A.F. Cailleux, S. Leboulleux, J.P. Travagli, M. Schlumberger, Positive predictive value of serum thyroglobulin levels, measured during the first year of follow-up after thyroid hormone withdrawal, in thyroid cancer patients. J. Clin. Endocrinol. Metab. 88(3), 1107\u20131111 (2003). https:\/\/doi.org\/10.1210\/jc.2002-021365","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1720_CR27","doi-asserted-by":"publisher","first-page":"i3839","DOI":"10.1136\/bmj.i3839","volume":"354","author":"M Banerjee","year":"2016","unstructured":"M. Banerjee, J.L. Wiebel, C. Guo, B. Gay, M.R. Haymart, Use of imaging tests after primary treatment of thyroid cancer in the United States: population based retrospective cohort study evaluating death and recurrence. BMJ 354, i3839 (2016). https:\/\/doi.org\/10.1136\/bmj.i3839","journal-title":"BMJ"},{"issue":"6","key":"1720_CR28","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1001\/jamaoto.2015.0596","volume":"141","author":"TE Fontenot","year":"2015","unstructured":"T.E. Fontenot, A. Deniwar, P. Bhatia, Z. Al-Qurayshi, G.W. Randolph, E. Kandil, Percutaneous ethanol injection vs reoperation for locally recurrent papillary thyroid cancer: a systematic review and pooled analysis. JAMA Otolaryngol. Head Neck Surg. 141(6), 512\u2013518 (2015). https:\/\/doi.org\/10.1001\/jamaoto.2015.0596","journal-title":"JAMA Otolaryngol. Head Neck Surg."},{"issue":"5","key":"1720_CR29","doi-asserted-by":"publisher","first-page":"1312","DOI":"10.1245\/s10434-010-1470-9","volume":"18","author":"JL Roh","year":"2011","unstructured":"J.L. Roh, J.M. Kim, C.I. Park, Central compartment reoperation for recurrent\/persistent differentiated thyroid cancer: patterns of recurrence, morbidity, and prediction of postoperative hypocalcemia. Ann. Surg. Oncol. 18(5), 1312\u20131318 (2011). https:\/\/doi.org\/10.1245\/s10434-010-1470-9","journal-title":"Ann. Surg. Oncol."},{"issue":"3","key":"1720_CR30","doi-asserted-by":"publisher","first-page":"365","DOI":"10.3109\/0284186X.2015.1102965","volume":"55","author":"C Hedman","year":"2016","unstructured":"C. Hedman, T. Djarv, P. Strang, C.I. Lundgren, Determinants of long-term quality of life in patients with differentiated thyroid carcinoma\u2014a population-based cohort study in Sweden. Acta Oncol. 55(3), 365\u2013369 (2016). https:\/\/doi.org\/10.3109\/0284186X.2015.1102965","journal-title":"Acta Oncol."},{"issue":"5","key":"1720_CR31","doi-asserted-by":"publisher","first-page":"340","DOI":"10.7326\/0003-4819-156-5-201203060-00005","volume":"156","author":"O Wegwarth","year":"2012","unstructured":"O. Wegwarth, L.M. Schwartz, S. Woloshin, W. Gaissmaier, G. Gigerenzer, Do physicians understand cancer screening statistics? A national survey of primary care physicians in the United States. Ann. Intern. Med. 156(5), 340\u2013349 (2012). https:\/\/doi.org\/10.7326\/0003-4819-156-5-201203060-00005","journal-title":"Ann. Intern. Med."},{"issue":"9","key":"1720_CR32","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1002\/cncr.28562","volume":"120","author":"CC Lubitz","year":"2014","unstructured":"C.C. Lubitz, C.Y. Kong, P.M. McMahon, G.H. Daniels, Y. Chen, K.P. Economopoulos, G.S. Gazelle, M.C. Weinstein, Annual financial impact of well-differentiated thyroid cancer care in the United States. Cancer 120(9), 1345\u20131352 (2014). https:\/\/doi.org\/10.1002\/cncr.28562","journal-title":"Cancer"},{"issue":"23","key":"1720_CR33","doi-asserted-by":"publisher","first-page":"4132","DOI":"10.1002\/cncr.29633","volume":"121","author":"LY Wang","year":"2015","unstructured":"L.Y. Wang, B.R. Roman, J.C. Migliacci, F.L. Palmer, R.M. Tuttle, A.R. Shaha, J.P. Shah, S.G. Patel, I. Ganly, Cost-effectiveness analysis of papillary thyroid cancer surveillance. Cancer 121(23), 4132\u20134140 (2015). https:\/\/doi.org\/10.1002\/cncr.29633","journal-title":"Cancer"},{"issue":"5","key":"1720_CR34","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0036626","volume":"7","author":"J Yaffe","year":"2012","unstructured":"J. Yaffe, P. Montgomery, S. Hopewell, L.D. Shepard, Empty reviews: a description and consideration of Cochrane systematic reviews with no included studies. PLoS One 7(5), e36626 (2012). https:\/\/doi.org\/10.1371\/journal.pone.0036626","journal-title":"PLoS One"},{"issue":"6","key":"1720_CR35","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1016\/j.jclinepi.2007.01.005","volume":"60","author":"A Lang","year":"2007","unstructured":"A. Lang, N. Edwards, A. Fleiszer, Empty systematic reviews: hidden perils and lessons learned. J. Clin. Epidemiol. 60(6), 595\u2013597 (2007). https:\/\/doi.org\/10.1016\/j.jclinepi.2007.01.005","journal-title":"J. Clin. Epidemiol."},{"issue":"6","key":"1720_CR36","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1016\/j.jclinepi.2007.02.001","volume":"60","author":"S Green","year":"2007","unstructured":"S. Green, J.P. Higgins, H.J. Schunemann, L. Becker, Response to paper by Lang A, Edwards N, and Fleiszer A. J. Clin. Epidemiol. 60(6), 598\u2013599 (2007). https:\/\/doi.org\/10.1016\/j.jclinepi.2007.02.001","journal-title":"J. Clin. Epidemiol."},{"issue":"2","key":"1720_CR37","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1111\/cts.12388","volume":"9","author":"P Selaru","year":"2016","unstructured":"P. Selaru, Y. Tang, B. Huang, A. Polli, K.D. Wilner, E. Donnelly, D.P. Cohen, Sufficiency of single-arm studies to support registration of targeted agents in molecularly selected patients with cancer: lessons from the clinical development of crizotinib. Clin. Transl. Sci. 9(2), 63\u201373 (2016). https:\/\/doi.org\/10.1111\/cts.12388","journal-title":"Clin. Transl. Sci."},{"issue":"1","key":"1720_CR38","doi-asserted-by":"publisher","first-page":"58","DOI":"10.7150\/jca.7047","volume":"5","author":"LJ Graham","year":"2014","unstructured":"L.J. Graham, M.P. Shupe, E.J. Schneble, F.L. Flynt, M.N. Clemenshaw, A.D. Kirkpatrick, C. Gallagher, A. Nissan, L. Henry, A. Stojadinovic, G.E. Peoples, N.M. Shumway, Current approaches and challenges in monitoring treatment responses in breast cancer. J. Cancer 5(1), 58\u201368 (2014). https:\/\/doi.org\/10.7150\/jca.7047","journal-title":"J. Cancer"},{"key":"1720_CR39","doi-asserted-by":"publisher","first-page":"CD002200","DOI":"10.1002\/14651858.CD002200.pub3","volume":"11","author":"M Jeffery","year":"2016","unstructured":"M. Jeffery, B.E. Hickey, P.N. Hider, A.M. See, Follow-up strategies for patients treated for non-metastatic colorectal cancer. Cochrane Database Syst. Rev. 11, CD002200 (2016). https:\/\/doi.org\/10.1002\/14651858.CD002200.pub3","journal-title":"Cochrane Database Syst. Rev."},{"issue":"6","key":"1720_CR40","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1016\/S2213-8587(17)30325-X","volume":"6","author":"G Grani","year":"2018","unstructured":"G. Grani, L. Lamartina, C. Durante, S. Filetti, D.S. Cooper, Follicular thyroid cancer and Hurthle cell carcinoma: challenges in diagnosis, treatment, and clinical management. Lancet Diabetes Endocrinol. 6(6), 500\u2013514 (2018). https:\/\/doi.org\/10.1016\/S2213-8587(17)30325-X","journal-title":"Lancet Diabetes Endocrinol."},{"issue":"3","key":"1720_CR41","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1016\/j.ejso.2017.07.013","volume":"44","author":"SL Gillanders","year":"2018","unstructured":"S.L. Gillanders, J.P. O\u2019Neill, Prognostic markers in well differentiated papillary and follicular thyroid cancer (WDTC). Eur. J. Surg. Oncol. 44(3), 286\u2013296 (2018). https:\/\/doi.org\/10.1016\/j.ejso.2017.07.013","journal-title":"Eur. J. Surg. Oncol."},{"issue":"7","key":"1720_CR42","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1093\/annonc\/mds230","volume":"23","author":"F Pacini","year":"2012","unstructured":"F. Pacini, M. Castagna, L. Brilli, G. Pentheroudakis, Thyroid cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann. Oncol. 23(7), 110\u2013119 (2012)","journal-title":"Ann. Oncol."}],"container-title":["Endocrine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12020-018-1720-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-018-1720-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-018-1720-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,4]],"date-time":"2023-09-04T12:38:43Z","timestamp":1693831123000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12020-018-1720-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8,20]]},"references-count":42,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,10]]}},"alternative-id":["1720"],"URL":"https:\/\/doi.org\/10.1007\/s12020-018-1720-3","relation":{},"ISSN":["1355-008X","1559-0100"],"issn-type":[{"value":"1355-008X","type":"print"},{"value":"1559-0100","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,8,20]]},"assertion":[{"value":"19 May 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 August 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 August 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}